Acompanhe as Notícias da Recifes

A genetic difference carried by nearly one in three people may increase the risk of severe COVID-19 and lung fibrosis by disrupting the function of a previously unknown protein, according to a new study published in Nature Communications.

Researchers led by Jiawei Yang, Worcester Polytechnic Institute (WPI) Assistant Professor in the Department of Mechanical and Materials Engineering, have designed a modular system that could potentially improve hydrogel implants in the body by customizing the materials for stiffn

For decades, lung disease has been the most visible and life-threatening part of cystic fibrosis. People might picture chronic (long-term) cough, breathlessness, recurrent chest infections and oxygen therapy.

Researchers have validated a genetic scoring tool that may help physicians diagnose idiopathic pulmonary fibrosis and identify which patients are at greatest risk for severe outcomes, including death or the need for a lung transplant. The findings come from a new international st

GLP-1 agonists have become popular treatments for weight loss and type 2 diabetes, and newer studies suggest other health benefits as well. Findings from experiments on mice, published in the Journal of Virology, suggest that the drugs may offer benefits to another patient popula

BBC Sport NI speaks to Irish golfer David Howard, who discusses being diagnosed with cystic fibrosis aged seven and qualifying for The Open at Royal Birkdale.

Pseudomonas aeruginosa is an opportunistic pathogen that can cause acute and chronic infections. Responsible for many hospital-acquired infections, it is also a major concern for people with cystic fibrosis, whose lungs are clogged with thick mucus that promotes its growth.